InsidersTradesSigma
Follow the 종근당바이오 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 종근당바이오 has published 2 public disclosures. The latest transaction was disclosed on 25 February 2026 (Other). Among the most active insiders: 종근당바이오. The full history is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
종근당바이오 是一家韩国公司，专注于健康和制药领域。该公司在 XKRX 证券交易所上市。